Advantech Capital
Private equityCamana Bay · Growth · 3 people tracked
Find your way into Advantech Capital
Sign up to see every warm intro you have to Advantech Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Advantech Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Advantech Capital is a private equity fund that invests in technology, media, telecommunications, pharmaceuticals, and healthcare companies in China.
Source: firm website, verified Oct 13, 2026.
Team · 3 people
from public directoriesWhat they invest in
from 2 of 3 portfolio companiesBiotech ×2Medical Devices ×2Digital Health ×1Healthtech ×1
HQs:China×1United States×1
Investments · 3 tracked
founders shown can be your intro pathZai Lab is a global biopharmaceutical company developing and commercializing therapies in oncology, immunology, neuroscience, and infectious disease, with operations in China and the United States.
BiotechHealthtechMedical Devices
Samantha (Ying) Du(Founder, Chief Executive Officer, Chairperson of the Board of Directors)inYajing Chen(Chief Financial Officer)inRafael G. Amado(President, Head of Global Research and Development)inF. Ty Edmondson(Chief Legal Officer)inJosh Smiley(President and Chief Operating Officer)Samantha Du(Founder)
Co-investorsQiming Venture PartnersVivo CapitalYuanBio Venture CapitalHongShan Capital GroupKleiner PerkinsSequoia Capital
Spot Biosystems is a clinical-stage biopharmaceutical company developing non-viral gene therapies using extracellular vesicles as a delivery method.
BiotechDigital HealthMedical Devices
Co-investorsSaltagen VenturesStartXIDG CapitalLDV Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 1
1 IPOsZai LabNASDAQ: ZLAB
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Zai Lab | 12.3% | $20.00 | Sep 2018 | $143.3M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- What stage does Advantech Capital invest at?
- Advantech Capital invests at the Growth stage.
- What sectors does Advantech Capital focus on?
- Advantech Capital focuses on Advanced Manufacturing, Biotech, Consumer, Data & Infrastructure, Enterprise Software, Healthtech, Media & Entertainment, Medical Devices, SaaS.
- Where is Advantech Capital located?
- Advantech Capital is headquartered in Camana Bay, CN.
Similar investors
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.
BGF is a UK and Ireland investor providing minority, patient growth capital and support to entrepreneurial small and medium-sized businesses, from early-stage deep tech and life sciences startups to established scaling companies.
EIFO (Export and Investment Fund of Denmark) is Denmark's national promotion bank and investment fund, providing financing, guarantees, and investments to help Danish companies grow, export, and support national priorities.
Advent International is a global private equity firm that partners with management teams to build market leaders through buyouts, corporate carve-outs, and value creation across selected sectors.
















